SIP
MDGL icon

Stoneridge Investment Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Stoneridge Investment Partners’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,834
Closed -$533K – 295
2015
Q2 		$533K Sell
6,834
-2,729
-29% -$229K 0.07% 199
2015
Q1 		$649K Buy
9,563
+70
+0.7% +$6K 0.08% 192
2014
Q4 		$880K Buy
9,493
+1,560
+20% +$161K 0.12% 165
2014
Q3 		$836K Sell
7,933
-7
-0.1% -$974 0.12% 166
2014
Q2 		$1.14M Buy
7,940
+6,043
+319% +$883K 0.17% 151
2014
Q1 		$286K Buy
+1,897
New +$374K 0.06% 163

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return